3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Primary Myelofibrosis
2
Myeloproliferative Disorders
2
Lymphoma, Non-Hodgkin
2
Thrombocytosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Melanoma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Hodgkin Disease
1
Carcinoma, Non-Small-Cell Lung
1
B-Cell Malignancies
1
Interventions
fludarabine phosphate
5
Whole-Body Irradiation
5
Mycophenolic Acid
5
Peripheral Blood Stem Cell Transplantation
4
Cyclosporins
4
Cyclosporine
4
carmustine, poliferprosan 20 drug combination
2
Sirolimus
2
Melphalan
2
Etoposide
2
Cytarabine
2
Cyclophosphamide
2
Carmustine
2
venetoclax
1
letermovir
1
ibrutinib
1
Tacrolimus
1
Stem Cell Transplantation
1
Interleukin-15
1
Hematopoietic Stem Cell Transplantation
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Prolymphocytic, T-Cell
×
itacitinib
×
Clear all
No trials found.